Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer

Pancreas

Volumn 22, Issue 3, 2001, Pages 285-292

  Tang, Rui Feng ^a,b   Itakura, Jun ^a,b   Aikawa, Takuma ^a,b   Matsuda, Kei ^a,b   Fujii, Hideki ^a,b   Korc, Murray ^a,b   Matsumoto, Yoshiro ^a,b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Flt 4; Human pancreatic cancer; Lymphangiogenesis; Vascular endothelial growth factor C

Indexed keywords

MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS;

BLOTTING, NORTHERN; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 0035086990     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200104000-00010     Document Type: Article

References (38)

1. Cancer statistics
2. Cancer statistics 1995
3. Cancer statistics 1997
4. The spread and prognosis of carcinoma in the region of the pancreatic head
5. A clinicopathologic study on neural invasion in cancer of the pancreatic head
6. Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro
7. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer
8. Studies on TNM classification of carcinoma of the exocrine pancreas
9. Clinical applications of research on angiogenesis
10. Angiogenesis and tumor growth
11. Vascular endothelial growth factor: Molecular and biological aspects
12. Structure, expression and receptor-binding properties of novel vascular endothelial growth factor
13. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
14. A novel type of vascular endothelial growth factor, VEGF-E (NA-7 VEGF), preferentially utilizes KDR/Flk-a receptor and carries a potent mitotic activity without heparin-binding domain
15. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
16. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
17. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
18. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
19. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
20. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer
21. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas
22. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression
23. Concomitant overexpression of vascular endothelial growth factor and its receptors in pancreatic cancer
24. Enhanced expression of the type II transforming growth factor β receptor in human pancreatic cancer cells without alteration of type III receptor expression
25. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha
26. Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells
27. Non parametric estimation for incomplete information
28. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
29. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
30. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
31. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
32. Differences in lymphatic and blood capillary permeability: Ultrastructural-functional correlations
33. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors
34. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
35. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
36. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3